Braunstein Scott
SEC-identified person · CIK 1643875 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Ataibeckley Inc. ATAI | Director | filed 2026 - 2026 |
| Rapt Therapeutics, Inc. RAPT | Director | filed 2025 - 2026 |
| Caribou Biosciences, Inc. CRBU | Director | filed 2021 - 2026 |
| Atai Beckley N.V. ATAI | Director | filed 2024 - 2025 |
| Marinus Pharmaceuticals, INC. NASDAQMRNS | Director · Executive Chairman | filed 2018 - 2025 |
| Trevena INC TRVN | Director | filed 2018 - 2024 |
| Constellation Pharmaceuticals INC CNST | Director | filed 2019 - 2021 |
| Protara Therapeutics, Inc. TARA | Director | filed 2020 - 2020 |
| Ziopharm Oncology INC ZIOP | Director | filed 2018 - 2020 |
| Esperion Therapeutics, Inc. ESPR | Director | filed 2015 - 2019 |
| Pacira Pharmaceuticals, Inc. PCRX | SVP, Strategy & Corp. Dev. | filed 2015 - 2018 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.